John Lansing's Trending123
John Lansing's Trending123
Username: Password: Login
Trade Talk E-Letter Products & Services Trading Tools Portfolios Members Home
Enter Symbol:
GPCB @ Yahoo Finance
GPCB Option @ Yahoo Finance
Stock Details
Current Price High Value Change Percent Change Dividend Previous Close
$ 4.43 $ 4.57 $ -0.17 -3.70% 0.00 $ 4.60
Opening Price Low Volume Market Cap Average Volume P/E
$ 4.55 $ 4.43 8,782 158.33M 30,709.25 0.00
Pivot Table
R2 R1 Pivot S1 S2
4.62 4.53 4.48 4.39 4.34

stock chart

GPC Biotech AG, a biopharmaceutical company, engages in the discovery and development of drugs to treat cancer. Its lead product candidate is satraplatin, an oral platinum-based compound intended for use as a chemotherapy drug. Satraplatin is being evaluated in a phase III registrational trial for second-line treatment of hormone refractory prostate cancer. The company's second product candidate, 1D09C3, is a monoclonal antibody intended for the treatment of selected leukemias and lymphomas, including nonHodgkin's lymphoma. Its another product candidate, RGB-286199, is a lead compound in a family of small molecule compounds that inhibit the cell cycle, which is essential for tumor growth. RGB-286199 is in preclinical development. GPC Biotech has a strategic alliance with ALTANA Pharma AG, which encompasses a technology transfer component, as well as research collaboration; and a co-development and license agreement with Pharmion Corp. for satraplatin, the oral platinum-based compound in advanced clinical development. The company was co-founded by Elmar Maier, Mirko Scherer, Sebastian Meier-Ewert, and David R. Bancroft as RM 102 Vermôgensverwaltungs GmbH in January 1997 and changed its name to Genome Pharmaceuticals Corporation GmbH in August 1997. The name was further changed to GPC Aktiengesellschaft Genome Pharmaceuticals Corporation in 1998 and to GPC Biotech AG in 2000. GPC Biotech is headquartered in Munich, Germany.

  • Premarket, intraday, nightly, and weekend updates, which include stock picks with full instructions, market direction (short, intermediate, long term), precious metal, commodity, and currency analysis.
  • Provide you stock picks (breakouts) and market direction to help you become
    more profitable.

  • Voice over chart updates sent to you by e-mail. These updates contain stock picks and market status for a number of different portfolios, which Trending123 is recommending and following.
  • Instantaneous e-mail alerts during the trading day when targets have been hit or the status of a position or the market warrants a move. Stock Recommendations for swing traders, day traders, and long term investors.
  • Receive instant emails to your computer, organizer, cell phone of breakouts on stocks.....Learn More